HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A
1Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, School of Basic Medical Sciences, Xuzhou Medical University, Xuzhou 221004, China
2Department of Clinical Laboratory, Heping Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China
3Department of Hepatology Division, Beijing Ditan Hospital Affiliated to Capital Medical University Xuzhou Hospital and Xuzhou Seventh People’s Hospital, Xuzhou 221004, China
4Department of Infectious Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China
5National Demonstration Center for Experimental Basic Medical Sciences Education, Xuzhou Medical University, Xuzhou 221004, China
收起